Heron Therapeutics Inc (NASDAQ:HRTX)

Tuesday’s trading has closed, but HRTX is being traded in the after-hours session. After-Hours quote »
11.14
Delayed Data
As of 3:59pm ET
 -0.39 / -3.38%
Today’s Change
6.51
Today|||52-Week Range
16.49
+10.74%
Year-to-Date
No recent news for Heron Therapeutics Inc.

Today’s Trading

Previous close11.53
Today’s open11.46
Day’s range10.87 - 11.70
Volume440,006
Average volume (3 months)253,093
Market cap$341.6M
Dividend yield--
Data as of 3:59pm ET, 05/05/2015

Growth & Valuation

Earnings growth (last year)+16.08%
Earnings growth (this year)-4.11%
Earnings growth (next 5 years)+64.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book5.34

Competitors

 Today’s
change
Today’s
% change
DRNADicerna Pharmaceutic...-0.61-3.16%
IDRAIdera Pharmaceutical...-0.07-2.50%
SNTASynta Pharmaceutical...-0.07-2.89%
CNCEConcert Pharmaceutic...-0.36-2.42%
Data as of 3:59pm ET, 05/05/2015

Financials

Next reporting dateMay 7, 2015
EPS forecast (this quarter)-$0.68
Annual revenue (last year)$0.00
Annual profit (last year)-$76.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Barry D. Quart
President, Director &
Chief Commercial Officer
Robert H. Rosen
Corporate headquarters
Redwood City, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers